Avant Diagnostics, Inc Purchase Agreements
9 Contracts & Agreements
- Asset Purchase Agreement, dated March 30, 2018, by and between Avant Diagnostics, Inc. and Amarantus Bioscience Holdings, Inc (Filed With SEC on April 6, 2018)
- Securities Purchase Agreement, dated September 5, 2017, by and between Avant Diagnostics, Inc. and the September 2017 Investor (Filed With SEC on September 26, 2017)
- Securities Purchase Agreement, dated August 8, 2017, by and between Avant Diagnostics, Inc. and the August 2017 Investor (Filed With SEC on September 26, 2017)
- Purchase Right, dated September 5, 2017, issued to the September 2017 Investor (Filed With SEC on September 26, 2017)
- Purchase Right, dated August 8, 2017, issued to the August 2017 Investor (Filed With SEC on September 26, 2017)
- Securities Purchase Agreement, dated June 19, 2017 by and between Avant Diagnostics, Inc. and the June 2017 Investor (Filed With SEC on June 21, 2017)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 11, 2016)
- ASSET PURCHASE AGREEMENT BETWEEN THERANOSTICS HEALTH, INC. (as Seller) AND AVANT DIAGNOSTICS, INC. (as Buyer) May 11, 2016 (Filed With SEC on May 17, 2016)
- ASSET PURCHASE AND SALE AGREEMENT (Filed With SEC on March 18, 2013)
